CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department

Abstract Introduction Our purpose was to compare the safety and efficacy of food and drug administration (FDA) recommended dosing of IV nicardipine versus IV labetalol for the management of acute hypertension. Methods Multicenter randomized clinical trial. Eligible patients had 2 systolic blood pres...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: W. Frank Peacock, Joseph Varón, Brigitte M. Baumann, Pierre Borczuk, Chad Cannon, Abhinav Chandra, David Cline, Deborah B. Diercks, Brian Hiestand, Amy P. Hsu, P. Jois-Bilowich, Brian Kaminski, Philip Levy, Richard M. Nowak, Jon W. Schrock
Format: Artigo
Jezik:engleski
Izdano: 2011
Online pristup:https://doi.org/10.1186/cc10289
https://ccforum.biomedcentral.com/counter/pdf/10.1186/cc10289
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!